Your browser is no longer supported. Please, upgrade your browser.
VRTX Vertex Pharmaceuticals Incorporated daily Stock Chart
VRTX [NASD]
Vertex Pharmaceuticals Incorporated
IndexS&P 500 P/E52.88 EPS (ttm)4.51 Insider Own0.10% Shs Outstand263.46M Perf Week9.70%
Market Cap62.79B Forward P/E23.39 EPS next Y10.19 Insider Trans-75.74% Shs Float258.92M Perf Month0.42%
Income1.18B PEG1.92 EPS next Q1.78 Inst Own97.20% Short Float1.20% Perf Quarter9.33%
Sales4.16B P/S15.08 EPS this Y118.10% Inst Trans0.02% Short Ratio1.67 Perf Half Y39.77%
Book/sh23.58 P/B10.11 EPS next Y32.52% ROA16.00% Target Price267.91 Perf Year29.41%
Cash/sh14.45 P/C16.49 EPS next 5Y27.55% ROE22.30% 52W Range163.68 - 249.85 Perf YTD8.84%
Dividend- P/FCF42.03 EPS past 5Y28.00% ROI14.70% 52W High-4.62% Beta1.00
Dividend %- Quick Ratio3.50 Sales past 5Y48.30% Gross Margin86.80% 52W Low45.59% ATR16.26
Employees3000 Current Ratio3.60 Sales Q/Q62.40% Oper. Margin28.80% RSI (14)54.87 Volatility6.30% 7.95%
OptionableYes Debt/Eq0.09 EPS Q/Q-62.40% Profit Margin28.30% Rel Volume1.06 Prev Close242.16
ShortableYes LT Debt/Eq0.09 EarningsApr 30 AMC Payout0.00% Avg Volume1.86M Price238.31
Recom1.90 SMA208.61% SMA503.76% SMA20017.94% Volume1,969,491 Change-1.59%
Mar-04-20Initiated Barclays Overweight $271
Jan-31-20Downgrade Robert W. Baird Outperform → Neutral $210 → $230
Nov-19-19Upgrade Guggenheim Neutral → Buy $252
Nov-12-19Initiated SunTrust Buy $235
Oct-17-19Resumed BofA/Merrill Buy $220
Sep-03-19Upgrade Goldman Neutral → Buy $226 → $254
Aug-01-19Downgrade Needham Buy → Hold
May-23-19Resumed Citigroup Buy $205
May-21-19Initiated Credit Suisse Outperform $209
Apr-12-19Initiated Evercore ISI In-line
Mar-26-19Upgrade William Blair Mkt Perform → Outperform
Mar-19-19Downgrade SVB Leerink Outperform → Mkt Perform
Feb-06-19Downgrade Maxim Group Buy → Hold
Jan-02-19Downgrade Raymond James Outperform → Mkt Perform
Oct-26-18Upgrade H.C. Wainwright Neutral → Buy $220
Oct-01-18Initiated Cantor Fitzgerald Overweight $217
Aug-07-18Reiterated Stifel Buy $182 → $200
Mar-05-18Reiterated Maxim Group Buy $195 → $200
Feb-13-18Reiterated JMP Securities Mkt Outperform $200 → $211
Feb-01-18Reiterated Barclays Overweight $180 → $200
Apr-04-20 08:00AM  Vertex Leads 5 Medical Stocks In Bullish Bases Amid Coronavirus Crisis Investor's Business Daily
Apr-03-20 05:45PM  Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know Zacks
03:59PM  Top Research Reports for Amazon, Medtronic & Vertex Zacks
08:09AM  Dow Jones Futures: After Strong Market Rally, Tesla Leaps On Q1 Deliveries; Two Leaders Eye New Buy Points Investor's Business Daily
Apr-02-20 10:19AM  Vertex enters new era of leadership, drug development American City Business Journals +7.40%
10:15AM  Healthcare stocks show their defensive allure in ailing market Reuters
10:00AM  These 3 Biotech Stocks Are Outperforming Their Peers Here's Why Investor's Business Daily
Apr-01-20 10:15AM  3 Drugmakers Still Worth Betting on Amid Coronavirus Woes Zacks -5.24%
08:10AM  Dow Jones Futures: Stock Market Rally Stalls As U.S. Coronavirus Cases Soar; Amazon, Microsoft, AMD Setting Up Investor's Business Daily
Mar-31-20 11:30AM  Is Vertex Pharmaceuticals (VRTX) Outperforming Other Medical Stocks This Year? Zacks
Mar-30-20 03:19PM  Vertex to Halt Enrollment Due to Coronavirus, Keeps Sales View Zacks +6.76%
Mar-29-20 11:49AM  Drug makers on shaky ground as clinical trials are postponed and drug launches delayed amid pandemic MarketWatch
Mar-27-20 08:14AM  Drugmaker Vertex to delay new clinical studies due to coronavirus Reuters
08:00AM  Vertex Confirms Supply Chain Continuity and Business Outlook for Its Cystic Fibrosis Medicines and Provides Initial Update on Development Programs Business Wire
Mar-26-20 05:43PM  Vertex Investor's Business Daily +6.85%
02:53PM  The Top 10 Biotechnology Companies Investopedia
09:52AM  Stock News: Dow Jones Scores Third Straight Bullish Gain Investor's Business Daily Video
Mar-25-20 04:06PM  Industries That Thrive During Recessions Investopedia -5.84%
Mar-24-20 04:23PM  Biotech stocks have held up better than the broader market and these five are potential winners MarketWatch +10.35%
Mar-23-20 04:24PM  IBD Stock Of The Day: Why Coronavirus Isn't Slamming This Biotech Leader Investor's Business Daily
03:08PM  IBD Stock Of The Day: Why Coronavirus Isn't Slamming This Biotech Leader Investor's Business Daily
Mar-20-20 05:58AM  Local companies, foundations scramble to help nonprofits in need American City Business Journals
Mar-19-20 11:56AM  Vertex Shows Relative Strength Investor's Business Daily Video
09:56AM  Nasdaq Starts New Rally Attempt With Bullish Gain Investor's Business Daily Video
Mar-18-20 05:45PM  Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know Zacks
Mar-17-20 09:38AM  Zacks.com featured highlights include: Fabrinet, Lumentum, Daqo New Energy and Vertex Pharmaceuticals Zacks +5.34%
09:27AM  The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals Zacks
Mar-16-20 12:31PM  Here are the BBJ's Business of Pride LGBT award honorees American City Business Journals -9.55%
10:42AM  4 Top Biotech Stocks to Buy in the Time of Coronavirus Zacks
Mar-14-20 08:00AM  Coronavirus Bear Market: All Stocks Are Under Quarantine, But Keep These Five Under Observation Investor's Business Daily
Mar-13-20 02:25PM  Were effectively hitting the pause button on the economy: Financial Analyst Yahoo Finance Video +8.23%
09:33AM  Geron's (GERN) Q4 Earnings and Revenues Surpass Estimates Zacks
08:42AM  Vertex donates $500k to Partners HealthCare for coronavirus testing American City Business Journals
08:00AM  Sustainability Investing Drives This Putnam Fund's Outperformance Investor's Business Daily
08:00AM  The Vertex Foundation Donates $500,000 to Partners HealthCare to Support COVID-19 Outbreak Response Business Wire
Mar-12-20 11:30AM  Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year? Zacks -7.39%
Mar-11-20 10:41PM  Hedge Funds Piled Into Vertex Pharmaceuticals (VRTX) Just In Time Insider Monkey
11:52AM  Should You Be Pleased About The CEO Pay At Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Simply Wall St.
11:51AM  3 Charts Suggest Traders Will Remain Bullish on Biotech Investopedia
08:14AM  Dow Jones Futures Tumble After Big Market Rally: Apple, Microsoft, Alibaba Flash Bullish Signal In Coronavirus Stock Market Correction Investor's Business Daily
Mar-09-20 02:27PM  Trump, White House officials to discuss economic response to coronavirus: Rpt Yahoo Finance Video -5.93%
09:52AM  Vertex Confirms Supply Chain Continuity and 2020 Business Outlook Business Wire
Mar-06-20 02:40PM  Stocks nosedive as coronavirus cases surpass 100K Yahoo Finance Video
08:13AM  Dow Jones Futures Dive: Apple, Tesla, Lead Nine Stocks To Watch In Coronavirus Stock Market Correction Investor's Business Daily
06:10AM  5 Biotech Stocks to Buy for a Strong Growth Prognosis InvestorPlace
Mar-05-20 02:47PM  Quest Diagnostics launching coronavirus test Yahoo Finance Video
06:11AM  Dozens of backers chime in on $100M round for hearing loss startup American City Business Journals
Mar-03-20 03:03PM  Inovio plans human trials of coronavirus vaccine in April Yahoo Finance Video
08:47AM  5 Top Stocks With Great Earnings Beat Potential Zacks
Mar-02-20 03:44PM  Vertex Announces Cancellation of its March 3 Presentation at the Cowen Health Care Conference Business Wire
02:34PM  Co-Diagnostics CEO on FDA's coronavirus policy changes Yahoo Finance Video
Feb-29-20 11:31AM  Why Is Vertex (VRTX) Down 2.7% Since Last Earnings Report? Zacks
Feb-27-20 02:02PM  Biotech outlook amid race to develop coronavirus vaccine Yahoo Finance Video
Feb-25-20 05:03PM  Vertex Announces Availability of Cystic Fibrosis Medicine KALYDECO® (ivacaftor) in New Zealand Business Wire
04:01PM  Vertex to Present at the Cowen Health Care Conference on March 3 Business Wire
11:30AM  Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year? Zacks
05:17AM  Here are the Mass.-based firms hit hardest in Monday's stock rout American City Business Journals
Feb-24-20 12:45PM  3 Reasons Why Vertex (VRTX) Is a Great Growth Stock Zacks
08:50AM  Looking for a Growth Stock? Why It is Time to Focus on Vertex (VRTX) Zacks
05:44AM  How biotech Alnylam plans to make a profit, and what stands in its way American City Business Journals
Feb-22-20 02:24PM  Wall Street has boosted 2020 estimates for these S&P 500 companies the most MarketWatch
Feb-21-20 08:16AM  Vertex Pharmaceuticals Could See More Gains but Weaker Momentum Is a Risk TheStreet.com
Feb-20-20 08:40AM  Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX) Zacks
Feb-19-20 07:59AM  Blood disorder startup files for $86M IPO American City Business Journals
Feb-18-20 07:04AM  Vertex's Cystic Fibrosis Franchise and Healthy Pipeline Support a Narrow Moat Rating Morningstar
Feb-14-20 10:11AM  What's in Store for Vertex in 2020 After a Remarkable 2019? Zacks
09:02AM  Vertex Is the Top Big Biotech, According to Citi. 3 More Stocks It Says to Buy. Barrons.com
Feb-12-20 09:32AM  Zacks.com featured highlights include: Chipotle Mexican Grill, Vertex Pharmaceuticals, ResMed, Spirit Airlines and OneMain Zacks
Feb-10-20 01:52PM  Edited Transcript of VRTX earnings conference call or presentation 30-Jan-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-06-20 04:43PM  How This IBD Stock Of The Day Clawed Its Way Above Two Buy Points Investor's Business Daily
07:24AM  Looking for another Apple or Amazon? These stocks have one important thing in common with techs big winners MarketWatch
Feb-05-20 12:45PM  3 Reasons Growth Investors Will Love Vertex (VRTX) Zacks
12:20PM  Why Vertex (VRTX) Might be Well Poised for a Surge Zacks
11:30AM  Is Vertex Pharmaceuticals (VRTX) Stock Outpacing Its Medical Peers This Year? Zacks
11:15AM  Biotech Stock Roundup: Earnings Updates From VRTX, AMGN, GILD; AIMT Gains FDA Nod Zacks
09:15AM  Vertex (VRTX) Hits 52-Week High, Can the Run Continue? Zacks
09:15AM  NASDAQ Reaches New Closing High as Rebound Continues Zacks
Feb-04-20 07:40PM  Buy this Cloud-Based Business Services Stock After Earnings on Strong Growth? Zacks
02:32PM  Eaton Vance Exits Celgene, Trims Amgen Position GuruFocus.com
08:41AM  Earnings Beat: Vertex Pharmaceuticals Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Simply Wall St.
Jan-31-20 03:02PM  Vertex (VRTX) Q4 Earnings Beat on Solid CF Product Sales Zacks
12:16PM  Don't Underestimate Vertex Pharmaceuticals TheStreet.com
09:50AM  Dow Jones Falls On Coronavirus Fears; Amazon Leads 3 Stocks Flashing Buy Signals Investor's Business Daily
09:09AM  The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO Benzinga
09:08AM  Vertexs Cystic Fibrosis Therapy Looks Like a Hit. Early Sales Shocked the Street. Barrons.com
05:04AM  Dow Jones Futures Fall: Amazon Surges On Earnings, Leads Four Stocks Flashing Buy Signals Investor's Business Daily
05:00AM  Families of rare-disease patients take on drug development, but face uphill battle American City Business Journals
Jan-30-20 05:15PM  Vertex Pharmaceuticals (VRTX) Q4 Earnings and Revenues Top Estimates Zacks
05:11PM  Top Biotech Vertex Pops After Crushing Fourth-Quarter Expectations Investor's Business Daily
04:27PM  Vertex Pharma stock rises on earnings, outlook beat MarketWatch
04:01PM  Vertex Reports Full-Year and Fourth-Quarter 2019 Financial Results Business Wire
11:06AM  Vertex Earnings, Revenue Beat in Q4 Investing.com
Jan-29-20 08:56AM  Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More Zacks
08:31AM  Why Vertex (VRTX) Might Surprise This Earnings Season Zacks
Jan-28-20 10:35AM  Can CF Drugs Drive Growth for Vertex (VRTX) in Q4 Earnings? Zacks
05:26AM  Acceleron stock soars on lung drug trial data American City Business Journals
Jan-23-20 05:50PM  Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: What You Should Know Zacks
12:31PM  Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: Should You Buy? Zacks
12:10PM  Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again Zacks
11:13AM  If You Had Bought Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Three Years Ago, You Could Pocket A 175% Gain Today Simply Wall St.
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for the treatment of cystic fibrosis (CF). The company markets TRIKAFTA, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with CF who have specific mutations in their CF transmembrane conductance regulator gene. It is also developing VX-814, which is in Phase II clinical trial and VX-864 that is in Phase I clinical trial for the treatment of alpha-1 antitrypsin deficiency; VX-147 for treating kidney diseases; and CTX001 that is in Phase I/II clinical trial for the treatment of beta-thalassemia and sickle cell diseases. In addition, the company develops VX-150, an inhibitor that is in Phase II clinical trial for acute, neuropathic, and musculoskeletal pain; and VX-561, a potentiator that is in Phase II clinical development; as well as evaluating VX-121, an additional corrector. It sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. The company has collaborations with CRISPR Therapeutics AG; Kymera Therapeutics Inc.; Parion Sciences, Inc.; BioAxone Biosciences, Inc.; Merck KGaA; Janssen Pharmaceuticals, Inc.; Arbor Biotechnologies, Inc.; Moderna Therapeutics, Inc.; Genomics plc; X-Chem, Inc.; Molecular Templates, Inc.; and Ribometrix, Inc. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tatsis OuraniaSVP, CROFeb 25Sale233.171,296302,18712,738Feb 26 04:39 PM
Silva Paul MSVP & ControllerFeb 25Sale233.451,080252,12714,932Feb 26 04:37 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 25Sale233.533,376788,40232,915Feb 26 04:36 PM
Parini MichaelEVP, CL&AOFeb 25Sale233.493,028707,00526,838Feb 26 04:35 PM
LEIDEN JEFFREY MCEO & PresidentFeb 25Sale233.4610,5502,463,04692,581Feb 26 04:34 PM
Kewalramani ReshmaEVP and CMOFeb 25Sale233.453,634848,37126,626Feb 26 04:32 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 25Sale233.743,634849,41835,179Feb 26 04:30 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 25Sale233.413,028706,77628,902Feb 26 04:29 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 18Sale243.673,128762,20134,346Feb 19 04:31 PM
Kewalramani ReshmaEVP and CMOFeb 18Sale243.511,183288,07033,158Feb 19 04:33 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 18Sale243.563,128761,84241,711Feb 19 04:32 PM
LEIDEN JEFFREY MCEO & PresidentFeb 18Sale243.5211,6852,845,518111,541Feb 19 04:35 PM
Parini MichaelEVP, CL&AOFeb 18Sale243.613,128762,02032,282Feb 19 04:36 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 18Sale243.563,489849,78039,447Feb 19 04:37 PM
Silva Paul MSVP & ControllerFeb 18Sale243.581,564380,95716,876Feb 19 04:38 PM
Tatsis OuraniaSVP, CROFeb 18Sale243.621,279311,58515,070Feb 19 04:39 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 11Sale246.1117,0324,191,77139,970Feb 12 05:11 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 11Sale246.0911,2862,777,32547,335Feb 12 05:13 PM
LEIDEN JEFFREY MCEO & PresidentFeb 11Sale246.0947,52311,694,933132,540Feb 12 05:19 PM
Parini MichaelEVP, CL&AOFeb 11Sale246.1116,8824,154,83237,906Feb 12 05:20 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 11Sale246.0813,0703,216,31146,198Feb 12 05:22 PM
Silva Paul MSVP & ControllerFeb 11Sale246.045,8621,442,30119,688Feb 12 05:24 PM
Lee YuchunDirectorFeb 10Option Exercise57.271,18167,6363,056Feb 12 05:14 PM
Lee YuchunDirectorFeb 10Sale242.511,181286,4031,875Feb 12 05:14 PM
Lee YuchunDirectorFeb 07Option Exercise57.272,000114,5403,875Feb 11 04:17 PM
Lee YuchunDirectorFeb 07Sale237.822,000475,6431,875Feb 11 04:17 PM
Silva Paul MSVP & ControllerFeb 06Option Exercise187.5346687,38930,689Feb 07 04:27 PM
Tatsis OuraniaSVP, CROFeb 06Option Exercise174.05967168,30217,913Feb 07 04:28 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 06Option Exercise173.512,787483,55970,350Feb 07 04:08 PM
Lee YuchunDirectorFeb 06Option Exercise57.272,000114,5403,875Feb 10 04:14 PM
Parini MichaelEVP, CL&AOFeb 06Option Exercise172.062,526434,61470,772Feb 07 04:17 PM
Kewalramani ReshmaEVP and CMOFeb 06Sale239.442,074496,60035,285Feb 07 04:14 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 06Sale239.422,787667,25367,563Feb 07 04:08 PM
Parini MichaelEVP, CL&AOFeb 06Sale239.422,526604,78368,246Feb 07 04:17 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 06Sale239.422,526604,77570,310Feb 07 04:07 PM
Tatsis OuraniaSVP, CROFeb 06Sale239.43967231,52716,946Feb 07 04:28 PM
Silva Paul MSVP & ControllerFeb 06Sale239.32466111,52330,223Feb 07 04:27 PM
Lee YuchunDirectorFeb 06Sale239.512,000479,0171,875Feb 10 04:14 PM
Lee YuchunDirectorFeb 05Option Exercise57.272,000114,5403,875Feb 06 04:06 PM
Lee YuchunDirectorFeb 05Sale242.382,000484,7631,875Feb 06 04:06 PM
Lee YuchunDirectorFeb 04Option Exercise57.273,028173,4143,875Feb 06 04:06 PM
Lee YuchunDirectorFeb 04Sale238.842,000477,6721,875Feb 06 04:06 PM
Parini MichaelEVP, CL&AOFeb 03Option Exercise86.522,330201,59235,989Feb 04 04:13 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 03Option Exercise88.494,126365,11735,679Feb 05 04:50 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 03Option Exercise88.904,097364,23940,287Feb 05 04:51 PM
Silva Paul MSVP & ControllerFeb 03Option Exercise89.302,099187,44919,858Feb 05 04:52 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 03Sale231.123,710857,46533,240Feb 04 04:10 PM
Lee YuchunDirectorFeb 03Sale231.102,000462,196847Feb 04 04:11 PM
Parini MichaelEVP, CL&AOFeb 03Sale231.144,4361,025,35031,553Feb 04 04:13 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 03Sale231.184,126953,86131,553Feb 05 04:50 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 03Sale231.114,097946,84536,190Feb 05 04:51 PM
Silva Paul MSVP & ControllerFeb 03Sale231.032,099484,93917,759Feb 05 04:52 PM
Silva Paul MSVP & ControllerJan 31Option Exercise187.531,396261,79219,155Feb 04 04:17 PM
SACHS BRUCE IDirectorJan 31Option Exercise53.8520,0001,077,00031,210Feb 04 04:15 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJan 31Option Exercise187.534,692879,89137,932Feb 04 04:10 PM
Parini MichaelEVP, CL&AOJan 31Option Exercise187.533,909733,05538,912Feb 04 04:13 PM
Parini MichaelEVP, CL&AOJan 31Sale238.653,909932,88335,003Feb 04 04:13 PM
Lee YuchunDirectorJan 31Sale228.022,000456,0422,847Feb 04 04:11 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJan 31Sale238.654,6921,119,74633,240Feb 04 04:10 PM
Silva Paul MSVP & ControllerJan 31Sale238.651,396333,15517,759Feb 04 04:17 PM
SACHS BRUCE IDirectorJan 31Sale227.9920,0004,559,83011,210Feb 04 04:15 PM
Parini MichaelEVP, CL&AOJan 22Option Exercise187.53118835,004Jan 24 04:10 PM
Parini MichaelEVP, CL&AOJan 22Sale237.50123835,003Jan 24 04:10 PM
Sachdev AmitEVP, Chief Patient OfficerJan 16Option Exercise109.145,000545,70041,190Jan 21 04:14 PM
Sachdev AmitEVP, Chief Patient OfficerJan 16Sale235.005,0001,175,00036,190Jan 21 04:14 PM
Parini MichaelEVP, CL&AOJan 13Option Exercise90.292,125191,86637,128Jan 15 04:08 PM
Silva Paul MSVP & ControllerJan 13Option Exercise90.2986077,64918,619Jan 15 04:09 PM
Parini MichaelEVP, CL&AOJan 13Sale226.782,125481,91135,003Jan 15 04:08 PM
Silva Paul MSVP & ControllerJan 13Sale229.38860197,26717,759Jan 15 04:09 PM
Sachdev AmitEVP, Chief Patient OfficerJan 08Option Exercise109.145,000545,70041,190Jan 10 04:46 PM
Tatsis OuraniaSVP, CROJan 08Option Exercise187.531,675314,1138,927Jan 10 04:22 PM
Silva Paul MSVP & ControllerJan 08Option Exercise131.8913,7501,813,48831,509Jan 10 04:32 PM
Sachdev AmitEVP, Chief Patient OfficerJan 08Sale230.005,0001,150,00036,190Jan 10 04:46 PM
Tatsis OuraniaSVP, CROJan 08Sale227.531,675381,1137,252Jan 10 04:22 PM
Silva Paul MSVP & ControllerJan 08Sale231.8913,7503,188,48817,759Jan 10 04:32 PM
Parini MichaelEVP, CL&AOJan 06Option Exercise122.454,250520,41339,253Jan 08 04:11 PM
Parini MichaelEVP, CL&AOJan 06Sale222.004,250943,51435,003Jan 08 04:11 PM
Silva Paul MSVP & ControllerJan 02Option Exercise102.3725,6302,623,81043,389Jan 06 04:17 PM
YOUNG WILLIAM DDirectorJan 02Option Exercise72.1420,0001,442,80029,311Jan 06 04:18 PM
Silva Paul MSVP & ControllerJan 02Sale218.9225,6305,610,99317,759Jan 06 04:17 PM
YOUNG WILLIAM DDirectorJan 02Sale218.9320,0004,378,6969,311Jan 06 04:18 PM
YOUNG WILLIAM DDirectorDec 30Option Exercise65.6530,0001,969,50039,311Jan 02 04:21 PM
YOUNG WILLIAM DDirectorDec 30Sale218.7630,0006,562,7159,311Jan 02 04:21 PM
Sachdev AmitEVP, Chief Patient OfficerDec 09Option Exercise109.145,000545,70038,416Dec 10 04:49 PM
Sachdev AmitEVP, Chief Patient OfficerDec 09Sale225.005,0001,125,00033,416Dec 10 04:49 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 25Option Exercise187.533,910733,24235,463Nov 26 04:11 PM
Kewalramani ReshmaEVP and CMONov 25Option Exercise187.534,692879,89117,790Nov 26 04:12 PM
Sachdev AmitEVP, Chief Patient OfficerNov 25Option Exercise109.145,000545,70038,416Nov 26 04:13 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 25Sale219.373,910857,73731,553Nov 26 04:11 PM
Kewalramani ReshmaEVP and CMONov 25Sale219.374,6921,029,28413,098Nov 26 04:12 PM
Sachdev AmitEVP, Chief Patient OfficerNov 25Sale220.005,0001,100,00033,416Nov 26 04:13 PM
LEIDEN JEFFREY MCEO & PresidentNov 19Option Exercise116.8096,53411,275,141202,880Nov 21 04:21 PM
Sachdev AmitEVP, Chief Patient OfficerNov 19Option Exercise109.145,000545,70038,416Nov 21 04:19 PM
LEIDEN JEFFREY MCEO & PresidentNov 19Sale210.9196,53420,360,052106,346Nov 21 04:21 PM
Sachdev AmitEVP, Chief Patient OfficerNov 19Sale215.005,0001,075,00033,416Nov 21 04:19 PM
LEIDEN JEFFREY MCEO & PresidentNov 18Option Exercise116.804,434517,893109,287Nov 19 04:12 PM
LEIDEN JEFFREY MCEO & PresidentNov 18Sale210.004,434931,140106,346Nov 19 04:12 PM
LEIDEN JEFFREY MCEO & PresidentNov 15Option Exercise116.805,000583,988109,663Nov 19 04:12 PM
Kewalramani ReshmaEVP and CMONov 15Sale205.956112,56313,098Nov 19 04:11 PM
Arbuckle Stuart AEVP\Chief Commercial OfficerNov 15Sale205.95193,91333,240Nov 19 04:09 PM